脏超声波预测,在托尔瓦普坦给药下,心力衰竭患者的功能恶化
Nobukiyo Tanaka1, Yoshio Furukawa1, Takuya Maeda1
1Department of Cardiovascular Medicine, Ichinomiya Nishi Hospital, 1 Kaimei-hira, Ichinomiya, 494-0001, Japan.
ESC heart failure
|March 12, 2024
概括
托尔瓦普坦在心力衰竭患者中增加了尿量和脏血流,但没有恶化功能. 动脉加速时间可能预测功能下降.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 功能障碍是慢性心力衰竭 (CHF) 的一个不良预后指标.
- 托尔瓦普坦是一种利尿剂,在慢性病 (CKD) 和心力衰竭 (HF) 中表现出有效性,而无功能损害.
- 这项研究研究了托尔瓦普坦对HF患者功能变化的影响和预测因素.
研究的目的:
- 评估tolvaptan对未补偿心力衰竭患者功能和血液动力学的影响.
- 为了确定在托尔瓦普坦治疗期间功能恶化的预测因素.
主要方法:
- 一个随机试验的后期分析,涉及201名心力衰竭患者.
- 在托尔瓦普坦给药前后进行脏超声波检查.
- 评估了尿液输出,摄入水和动脉多普勒参数.
主要成果:
- 托尔瓦普坦增加了尿液输出和水的摄入量,而体重,血压,心率或估计的淋巴膜过率 (eGFR) 没有显著变化.
- 间叶动脉的峰值静脉缩速度 (PSV) 和末端静脉缩速度 (EDV) 在tolvaptan后显著增加.
- 动脉加速时间 (AT) 与eGFR变化呈负相关性.
结论:
- 托尔瓦普坦的使用可能会增强脏血液流动,通过增加腹腔间动脉PSV和EDV来表明.
- 动脉AT可以作为预测心力衰竭患者功能恶化的潜在代用标记.
更多相关视频
07:59Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
Published on: July 28, 2018
11.2K
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
20.2K
相关概念视频
01:22Heart Failure Drugs: Diuretics
375
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
375
01:11Renal Failure: Dose Adjustments
88
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429
01:17Factors Affecting Renal Clearance: Renal Impairment
91
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
91
01:20Imaging Studies for Cardiovascular System III: X-Ray
188
The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
188